Elif I. Ekinci — ASN Events

Elif Ekinci

The University of Melbourne, VIC, Australia

  • This delegate is presenting an abstract at this event.
Dr Elif Ekinci is an academic endocrinologist who is working to translate research into improved outcomes for people with type 1 and type 2 diabetes. She is the Sir Edward Dunlop Medical Research Foundation Senior Fellow in Metabolic Medicine at The University of Melbourne, Department of Medicine, Austin Health. Her research focus is diabetes and its complications, aiming to significantly improve clinical practice and health outcomes. Her research streams include the following: (i) effects of diabetes on kidney function (ii) effects of dietary sodium intake in people with diabetes (iii) improving the management of diabetes in the inpatient setting (iv) improving the management of diabetes for Indigenous Australians living in remote and rural communities (v) effects of pre-existing diabetes on pregnancy She is also the Director of Diabetes at Austin Health where she co-ordinates the clinical care of inpatients and outpatients with diabetes. She heads Diabetes and Obesity clinical trials at Austin Health and The University of Melbourne where she is the Chief Investigator in numerous clinical trials. Dr Ekinci has 65 publications including in the following journals: Diabetes Care, Diabetes, Diabetologia, Clinical Science, Diabetic Medicine, AJKD, Kidney International, MJA. She has co-authored more than 100 abstracts at various national and international meetings. She supervises PhD students and MDRP students and also mentors endocrinologists, endocrine registrars, residents, interns, medical students and clinical trials staff. She has obtained a total of over $4 million of research funding along with her colleagues, including funding from the NHMRC.
Presentations this author is a contributor to:

Improving the Transition of Care of Inpatients with Type 2 Diabetes (#264)

2:00 PM
Felicity Pyrlis
ADS Clinical Poster Session - Therapy of type 2 diabetes

Soluble urokinase plasminogen activator receptor (suPAR) levels and decline in estimated glomerular filtration rate (eGFR) in patients with diabetes (#31)

11:15 AM
Richard MacIsaac
ADS Clinical Orals - Renal & Foot Complications

Initiating injectable therapy in hospital versus the home:  experiences of people with type 2 diabetes and diabetes team providing care (#389)

2:00 PM
Rajna Ogrin
ADEA Poster Viewing Two

The contribution of glycaemic status to the progression of kidney disease among Indigenous Australians with and without albuminuria– the eGFR follow-up study (#30)

11:00 AM
Elizabeth LM Barr
ADS Clinical Orals - Renal & Foot Complications

The Effect Of Salt Versus Placebo Supplementation On Haematocrit Levels In Type Two Diabetes Mellitus (#321)

2:00 PM
Adrian Michalopoulos
ADS Clinical Poster Session - Diabetes Complications (general)

The Prevalence of Diabetes Mellitus and its Association with Stroke Inpatient Outcomes   (#7)

9:30 AM
Jeremy Lew
ADS Clinical Orals - Epidemiology & Cardiovascular Complications

Targeting the C5a-C5aR1 Signalling Axis in Diabetic Nephropathy (#13)

9:00 AM
Melinda T Coughlan
ADS Basic Orals - Diabetes Complications

Are the diagnoses of diabetes and sarcopenia associated with patients' progress in inpatient rehabilitation? A systematic literature review (#254)

2:00 PM
Irina Churilov
ADS Clinical Poster Session - Type 2 Diabetes (general)